TGEN
Tecogen Inc.
NYSE AmericanUSDEQUITY
DELAYED
Last price
3.38
▲ 0.12 (3.68%)
MARKET · —
Price
Too many bars for candle bodies at this width — showing high/low range per bar. Zoom in or pick a shorter range.
Open
3.18
Prev close
3.26
Day high
3.47
Day low
3.27
Volume
217.97K
Market cap
—
P/E (TTM)
—
52W range
1.94 – 12.07
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Trailing performance
Returnvs SPY
1W
-6.30%
-4.9%
1M
+0.59%
-3.1%
3M
-38.04%
-41.1%
6M
-3.39%
-14.5%
YTD
-30.77%
-43.1%
1Y
-58.24%
-78.2%
3Y
+235.29%
+161.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $27.07M | $22.62M | $25.14M | $25.00M | +19.7% |
| Operating revenue | $27.07M | $22.62M | $25.14M | $25.00M | +19.7% |
| Cost of revenue | $17.25M | $12.75M | $14.94M | $13.94M | +35.3% |
| Gross profit | $9.82M | $9.87M | $10.20M | $11.07M | -0.5% |
| Research & development | $1.17M | $961.84K | $840.01K | $732.87K | +21.3% |
| Selling, general & admin | $15.79M | $13.24M | $13.81M | $12.72M | +19.3% |
| Total operating expense | $16.96M | $14.20M | $14.65M | $13.45M | +19.4% |
| Operating income | -$7.13M | -$4.33M | -$4.45M | -$2.39M | -64.7% |
| Net interest income | $1.42K | -$117.12K | -$77.05K | -$50.97K | +101.2% |
| Pre-tax income | -$8.23M | -$4.65M | -$4.49M | -$2.38M | -76.9% |
| Tax provision | $20.61K | $22.57K | $32.49K | $16.35K | -8.6% |
| Net income | -$8.25M | -$4.76M | -$4.60M | -$2.45M | -73.3% |
| Net income to common | -$8.25M | -$4.76M | -$4.60M | -$2.45M | -73.3% |
| Basic EPS | -0.30 | -0.19 | -0.19 | -0.10 | -57.9% |
| Diluted EPS | -0.30 | -0.19 | -0.19 | -0.10 | -57.9% |
| EBIT | -$8.08M | -$4.53M | -$4.41M | -$2.33M | -78.2% |
| EBITDA | -$7.20M | -$3.98M | -$3.85M | -$1.90M | -80.9% |
| Basic shares | 27.23M | 24.86M | 24.85M | 24.85M | +9.5% |
| Diluted shares | 27.23M | 24.86M | 24.85M | 24.85M | +9.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $12.43M | $5.41M | $1.35M | $1.91M | +130.0% |
| Cash & short-term investments | $12.43M | $5.41M | $1.35M | $1.91M | +130.0% |
| Accounts receivable | $4.28M | $6.03M | $6.74M | $6.71M | -29.0% |
| Inventory | $10.95M | $9.63M | $10.55M | $10.48M | +13.7% |
| Total current assets | $28.89M | $22.15M | $20.31M | $22.03M | +30.4% |
| Property, plant & equipment | $3.10M | $3.47M | $1.91M | $2.65M | -10.6% |
| Goodwill & intangibles | $3.39M | $4.86M | $5.18M | $3.40M | -30.1% |
| Total assets | $36.99M | $31.09M | $27.79M | $28.25M | +19.0% |
| Total current liabilities | $9.27M | $16.82M | $10.48M | $7.69M | -44.9% |
| Current debt | — | $1.55M | $505.50K | — | — |
| Total debt | $2.82M | $3.73M | $1.48M | $1.31M | -24.6% |
| Total liabilities | $15.52M | $20.97M | $13.14M | $9.27M | -26.0% |
| Retained earnings | -$55.89M | -$47.64M | -$42.88M | -$38.28M | -17.3% |
| Shareholder equity | $21.65M | $10.23M | $14.75M | $19.09M | +111.6% |
| Working capital | $19.62M | $5.33M | $9.82M | $14.34M | +268.1% |
| Net tangible assets | $18.25M | $5.37M | $9.57M | $15.69M | +239.8% |
| Shares issued | 29.85M | 24.95M | 24.85M | 24.85M | +19.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$8.25M | -$4.67M | -$4.52M | -$2.40M | -76.5% |
| Depreciation & amortisation | $877.67K | $553.78K | $567.71K | $428.35K | +58.5% |
| Stock-based compensation | $348.03K | $172.99K | $250.39K | $334.15K | +101.2% |
| Change in working capital | -$4.20M | $7.54M | $1.61M | $153.28K | -155.7% |
| Operating cash flow | -$9.91M | $4.06M | -$817.81K | -$1.35M | -344.1% |
| Capital expenditure | -$400.78K | -$969.16K | -$46.85K | -$344.38K | +58.6% |
| Investing cash flow | -$464.13K | -$1.01M | -$244.89K | -$348.56K | +54.3% |
| Financing cash flow | $17.40M | $1.01M | $500.00K | $0 | +1,626.0% |
| Free cash flow | -$10.31M | $3.09M | -$864.66K | -$1.70M | -433.6% |
| End cash position | $12.43M | $5.41M | $1.35M | $1.91M | +130.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $6.34M | $5.32M | $7.18M | $7.29M | $7.28M | +19.1% |
| Operating revenue | $6.34M | $5.32M | $7.18M | $7.29M | $7.28M | +19.1% |
| Cost of revenue | $3.75M | $3.36M | $5.00M | $4.83M | $4.06M | +11.5% |
| Gross profit | $2.59M | $1.96M | $2.18M | $2.46M | $3.22M | +32.3% |
| Research & development | $363.82K | $307.43K | $297.93K | $268.72K | $292.67K | +18.3% |
| Selling, general & admin | $4.36M | $4.68M | $3.98M | $3.61M | $3.52M | -6.8% |
| Total operating expense | $4.72M | $4.98M | $4.28M | $3.87M | $3.82M | -5.2% |
| Operating income | -$2.13M | -$3.03M | -$2.10M | -$1.41M | -$594.24K | +29.5% |
| Net interest income | -$34.24K | $113.01K | -$41.11K | -$38.15K | -$32.33K | -130.3% |
| Pre-tax income | -$2.11M | -$4.00M | -$2.12M | -$1.46M | -$659.56K | +47.3% |
| Tax provision | $10.90K | $0 | $2.93K | $16.76K | $925 | — |
| Net income | -$2.12M | -$3.99M | -$2.13M | -$1.46M | -$659.92K | +46.9% |
| Net income to common | -$2.12M | -$3.99M | -$2.13M | -$1.46M | -$659.92K | +46.9% |
| Basic EPS | -0.07 | -0.13 | -0.07 | -0.06 | -0.03 | +46.2% |
| Diluted EPS | -0.07 | -0.13 | -0.07 | -0.06 | -0.03 | +46.2% |
| EBIT | -$2.07M | -$3.96M | -$2.08M | -$1.42M | -$627.24K | +47.6% |
| EBITDA | -$1.81M | -$3.70M | -$1.84M | -$1.21M | -$441.54K | +51.2% |
| Basic shares | 29.86M | 29.84M | 28.82M | 25.25M | 24.95M | +0.1% |
| Diluted shares | 29.86M | 29.84M | 28.82M | 25.25M | 24.95M | +0.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $9.33M | $12.43M | $15.25M | $1.64M | $4.07M | — | -24.9% |
| Cash & short-term investments | $9.33M | $12.43M | $15.25M | $1.64M | $4.07M | — | -24.9% |
| Accounts receivable | $5.06M | $4.28M | $6.22M | $6.64M | $5.85M | — | +18.1% |
| Inventory | $11.44M | $10.95M | $9.56M | $9.68M | $9.89M | — | +4.5% |
| Total current assets | $26.55M | $28.89M | $32.08M | $19.04M | $20.61M | — | -8.1% |
| Property, plant & equipment | $2.92M | $3.10M | $3.40M | $2.75M | $2.42M | — | -5.6% |
| Goodwill & intangibles | $3.31M | $3.39M | $4.58M | $4.68M | $4.77M | — | -2.6% |
| Total assets | $34.46M | $36.99M | $41.46M | $28.35M | $29.73M | — | -6.8% |
| Total current liabilities | $8.80M | $9.27M | $11.82M | $13.97M | $14.95M | — | -5.1% |
| Current debt | — | — | — | — | $512.19K | $1.55M | — |
| Long-term debt | — | — | — | $1.07M | $1.06M | — | — |
| Total debt | $2.86M | $2.82M | $2.85M | $3.69M | $3.95M | — | +1.4% |
| Total liabilities | $14.92M | $15.52M | $16.15M | $19.41M | $20.21M | — | -3.8% |
| Retained earnings | -$58.01M | -$55.89M | -$51.89M | -$49.76M | -$48.30M | — | -3.8% |
| Shareholder equity | $19.71M | $21.65M | $25.46M | $9.10M | $9.65M | — | -8.9% |
| Working capital | $17.75M | $19.62M | $20.26M | $5.07M | $5.67M | — | -9.5% |
| Net tangible assets | $16.41M | $18.25M | $20.88M | $4.42M | $4.88M | — | -10.1% |
| Shares issued | 29.91M | 29.85M | 29.82M | 25.57M | 24.99M | — | +0.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$2.12M | -$4.00M | -$2.12M | -$1.47M | -$660.49K | +47.0% |
| Depreciation & amortisation | $265.24K | $256.14K | $230.15K | $205.69K | $185.69K | +3.5% |
| Stock-based compensation | $131.67K | $138.17K | $126.42K | $42.61K | $40.83K | -4.7% |
| Change in working capital | -$1.42M | -$219.47K | -$1.89M | -$1.39M | -$702.04K | -545.2% |
| Operating cash flow | -$3.11M | -$2.58M | -$3.56M | -$2.60M | -$1.17M | -20.7% |
| Capital expenditure | -$46.12K | -$47.48K | -$75.31K | -$145.97K | -$132.02K | +2.9% |
| Investing cash flow | $50.35K | -$69.16K | -$74.31K | -$155.76K | -$164.91K | +172.8% |
| Financing cash flow | -$39.86K | -$179.28K | $17.25M | $332.04K | -$128 | +77.8% |
| Free cash flow | -$3.15M | -$2.62M | -$3.64M | -$2.75M | -$1.31M | -20.3% |
| End cash position | $9.33M | $12.43M | $15.25M | $1.64M | $4.07M | -24.9% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
3.69
-8.40% from price
SMA 20
3.58
-4.51% from price
SMA 50
4.22
-18.99% from price
SMA 100
4.52
-25.16% from price
SMA 200
4.66
-26.65% from price
EMA 12
3.58
-5.56% from price
EMA 26
3.74
-9.72% from price
EMA 50
4.04
-16.40% from price
RSI (14)
41.6
Neutral
MACD (12,26,9)
-0.16
Hist 0.00
ATR (14)
0.32
9.24% of price
Realised vol 30D
75.1%
Annualised
Bollinger upper
4.23
20, 2σ
Bollinger lower
2.94
20, 2σ
50 / 200 cross
Death
4.22 vs 4.66
Trend bias
Below 200
-26.65%
Risk profile
Beta vs SPY
3.54
More volatile than market
Correlation to SPY
0.42
Loosely linked
Realised vol 30D
75.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-83.4%
Peak to trough
Max drawdown 5Y
-83.4%
Peak to trough
ATR 14
0.32
9.24% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Tecogen (TGEN) Q2 2026 Earnings Call Transcript
Motley Fool · 3d ago
Tecogen Inc (TGEN) (Q2 2026) Earnings Call Highlights: Data Center Momentum Offsets Revenue Dip
GuruFocus.com · 5d ago
Tecogen Q2 Earnings Call Highlights
MarketBeat · 9d ago
Tecogen Inc. Q2 2026 Earnings Call Summary
Moby · 9d ago
Tecogen Inc. (TGEN) Reports Q2 Loss, Misses Revenue Estimates
Zacks · 10d ago
Tecogen Reports Second Quarter 2026 Financial Results
ACCESS Newswire · 10d ago
Aaon (AAON) Surpasses Q2 Earnings and Revenue Estimates
Zacks · 13d ago
Fortune Brands Innovations (FBIN) Q2 Earnings Beat Estimates
Zacks · 18d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.